Peripheral Vascular Devices | Europe | 2018 | Market Analysis
The European market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2026.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Europe across a 10-year period.
Peripheral DCBs have experienced strong growth in the years following their commercial launch.
To what degree will DCBs be adopted in Europe over the forecast period?
Which countries will see the fastest growth in these markets?
Will DCBs or DES become the standard drug-eluting solution for BTK lesions?
How many competitors will enter the DCB market, and who will gain the most market share?
How will DCB uptake affect other PV devices such as stents, normal balloon catheters, and atherectomy devices?
Will the emergence of DCBs have an impact on recently established DES usage?
Which new indications will drive growth in the DCB market?
Recent mergers and acquisitions will affect the European PV device market.
Which companies pose a challenge to established leaders and in which markets?
Which companies will gain market entry as a result of recent mergers and acquisitions?
Budgetary constraints continue to affect the European PV device market, especially in Italy.
What effect are GPOs having on the European PV device market?
How fast will ASPs erode and which countries will experience the greatest erosion?
How can companies mitigate this downward pressure in pricing?
